Page 19 - Device Designation News Today

As part of the agreement, SoftBank will research market opportunities for the digital therapeutic, and it can negotiate an exclusive commercialization deal in Japan.

Read the latest Vermont Schools headlines - updated 24/7/365. We link to the best sources from around the world. Get the latest on Vermont Schools...

Also: OpenLoop raises $8 million for its virtual care staffing and support services, and metaMe Health scoops up $2.2 million to prepare for the market launch of its prescription digital therapeutic.

Also: the Surgeon General asks big tech for COVID-19 misinformation data, and Eden Health launches a personal care offering.

/PRNewswire/ -- Altoida, Inc. an artificial intelligence (AI) company pioneering next-generation neurological disease diagnostics and brain health solutions,...

/PRNewswire/ -- Altoida, Inc. an artificial intelligence (AI) company pioneering next-generation neurological disease diagnostics and brain health solutions,...

Dexcom CGM to be evaluated for performance in the hospital and for the potential of more effective glycemic management and improved patient outcomes in the hospital settingBreakthrough Device Designation from the FDA is a critical milestone for in-patient Dexcom CGM useThis designation provides a more efficient and...

Cognito Therapeutics, a late-stage company pioneering non-invasive optogenetics-based therapies for neurodegenerative diseases, announced today it will present a virtual symposium featuring a panel

HEIDELBERG, GERMANY / ACCESSWIRE / February 22, 2022 / Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE brain

Investegate announcements from PRECISIS GmbH, Minimally Invasive Epilepsy Treatment EASEE Receives FDA Breakthrough Device Designation